Company: GAUZ
Filing Date: 2025-07-03
Form Type: F-3
Source: 0001213900-25-061387
Chunk: 15

Company: Gauzy Ltd.
Filing Date: 2025-07-03
Form: F-3
Chunk 15
---
 we will file from time to time with the SEC after the date
of this prospectus. We qualify all of our forward-looking statements by these cautionary statements.

<div align='center'>7

CAPITALIZATION</div>

We intend to include information
about our capitalization and indebtedness in the prospectus and applicable prospectus supplements.

<div align='center'>OFFER AND LISTING DETAILS</div>

Our ordinary shares have
been traded on the Nasdaq Global Market under the symbol “GAUZ” since June 6, 2024.

<div align='center'>USE OF PROCEEDS</div>

Unless otherwise indicated
in an accompanying prospectus supplement, the net proceeds from the sale of securities will be used for general corporate purposes, including
the purchase of equipment and materials for the expansion of our production lines, research and development, advertising and marketing,
technology development, working capital, operating expenses and other general corporate purposes.

<div align='center'>DESCRIPTION OF ORDINARY SHARES</div>

Our authorized share capital consists of 49,200,191
ordinary shares, no par value, of which 18,742,093 ordinary shares were issued and outstanding as of June 26, 2025.

All of our issued and outstanding ordinary shares
have been validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and are not subject to preemptive rights.
All ordinary shares have identical voting and other rights in all respects.

For a further description of our ordinary shares,
see Exhibit 2.1 to our Annual Report.

<div align='center'>8

DESCRIPTION OF WARRANTS</div>

We may issue warrants to purchase our ordinary
shares. Warrants may be issued independently or together with any other securities and may be attached to, or separate from, such securities.
Each series of warrants will be issued under a separate warrant agreement, which may be entered into between us and a warrant agent specified
in an applicable prospectus supplement relating to a particular series of warrants. Any such warrant agent will act solely as our agent
and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. We may also choose
to act as our own warrant agent. The terms of any warrants to be issued and a description of the material provisions of the applicable
warrant agreement will be set forth in the applicable prospectus supplement.

The applicable prospectus supplement will describe
the following terms of any warrants in respect of which this prospectus is being delivered: